A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer. - van Veggel, Bianca A. M. H.; van der Wekken, Anthonie J.; Paats, Marthe S.; Hendriks, Lizza E. L.; Hashemi, Sayed M. S.; Daletzakis, Antonios; van den Broek, Daan; Bosch, Linda J. W.; Monkhorst, Kim; Smit, Egbert F.; de Langen, Adrianus J. (Cancer (0008543X), 2024)